Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes

NCT01615978 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: liraglutide
DRUG: liraglutide
DRUG: placebo

Sponsor

Novo Nordisk A/S